Tue, 13 Oct 2026
in 76 daysEPS estimate
$3.08
Wall Street consensus
Revenue estimate
$25.6B
Wall Street consensus
Expected swing
±10.0%
±1σ by report day, from realized volatility
Odds turned into a number: where the print lands if JNJ's usual surprise repeats — and what the crowd's beat odds imply on the same scale.
Live odds from the community — tap through to make your own call.
Analyst consensus — and whether it has been improving or souring into the print.
Buy
31 analysts · 21 buy · 10 hold · 0 sell
Reported EPS against the Street's estimate, most recent first — the same feed our earnings questions settle on.
Beat rate
3 of 4
quarters beat the estimate
Avg surprise
+0.4%
vs EPS estimate
| Quarter | Estimate | Actual | Surprise | Result |
|---|---|---|---|---|
| Jun 2026 | $2.87 | $2.90 | +0.9% | BEAT |
| Mar 2026 | $2.69 | $2.70 | +0.3% | BEAT |
| Dec 2025 | $2.46 |
Trailing-twelve-month figures for context around the print.
Market cap
$648.9B
EPS (TTM)
$8.62
P/E (TTM)
30.8
price ÷ trailing earnings
Revenue growth
+8.1%
TTM vs a year ago
Gross margin
68.0%
of revenue kept after costs
Net margin
21.5%
of revenue kept as profit
52-week range
$164 – $275
now $266.73
Beta
0.22
steadier than the market
Dividend yield
1.95%
Estimates and reported figures via Finnhub; crowd odds are Johnson & Johnson forecasts on Probs. Information, not investment advice.
See the implied EPS
Premium turns the crowd's beat odds into a dollar figure and shows where JNJ's print lands if its usual surprise repeats.
| $2.46 |
| -0.1% |
| MISS |
| Sept 2025 | $2.78 | $2.80 | +0.5% | BEAT |
trailing twelve months